BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Queensland Health
Johnson and Johnson
Daiichi Sankyo
Cantor Fitzgerald

Generated: December 18, 2017

DrugPatentWatch Database Preview

Ephedrine sulfate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ephedrine sulfate and what is the scope of ephedrine sulfate patent protection?

Ephedrine sulfate
is the generic ingredient in three branded drugs marketed by Flamel Ireland Ltd, Akorn Inc, Sandoz Inc, and Par Sterile Products, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty-seven drug master file entries for ephedrine sulfate. Four suppliers are listed for this compound.

Medical Subject Heading (MeSH) Categories for ephedrine sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz IncEPHEDRINE SULFATEephedrine sulfateSOLUTION;INTRAVENOUS209784-001Aug 23, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Par Sterile ProductsCORPHEDRAephedrine sulfateSOLUTION;IV (INFUSION)208943-001Jan 27, 2017RXNoNo► Subscribe► Subscribe► Subscribe
Akorn IncEPHEDRINE SULFATEephedrine sulfateSOLUTION;INTRAVENOUS208609-001Mar 1, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Flamel Ireland LtdAKOVAZephedrine sulfateSOLUTION;INTRAVENOUS208289-001Apr 29, 2016APRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Chinese Patent Office
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: